Home
MPM Asset Management, 10% Owner: Aktis Oncology AKTS Buy · Filed 01/14
Trade details
- Type
- Insider buy
- Amount
- $20,029,986
- Shares · price
- 1,112,777 sh · $18.00 a share
- Held after
- 10,260,064 sh
- Stock
- Aktis Oncology AKTS
- Trade date
- 26/01/12
- Filed
- 26/01/14
- Days to filing
- 2 days
First buy since 2023
- Insiders buying this week
- 17 insiders
- Holding change
- +12.2%
Aktis Oncology trades, last 26 weeks
What else happened in Aktis Oncology around then
Filed or reported within 30 days of the trade day · 25/12/13~02/11MPM Asset Management's recent trades
- MPM Asset Management
Planned sale10b5-1 planWerewolf Therapeutics
Planned sale10b5-1 planWerewolf Therapeutics
HOWL
$5,222
15,341 sh
$5,222
Filed 07/06
Traded 07/06
- MPM Asset Management
Planned sale10b5-1 planWerewolf Therapeutics
Planned sale10b5-1 planWerewolf Therapeutics
HOWL
$5,436
16,830 sh
$5,436
Filed 06/29
Traded 06/29
- MPM Asset Management
Planned sale10b5-1 planWerewolf Therapeutics
Planned sale10b5-1 planWerewolf Therapeutics
HOWL
$19K
38,675 sh
$19K
Filed 05/28
Traded 05/28
- MPM Asset Management
Planned sale10b5-1 planWerewolf Therapeutics
Planned sale10b5-1 planWerewolf Therapeutics
HOWL
$23.7K
45,998 sh
$23.7K
Filed 05/18
Traded 05/18
- MPM Asset Management
Planned sale10b5-1 planWerewolf Therapeutics
Planned sale10b5-1 planWerewolf Therapeutics
HOWL
$9,100
13,382 sh
$9,100
Filed 05/11
Traded 05/11